Neurontin

Seizure Management

Neurontin is used as an add-on treatment for partial onset seizures in adults and children aged 3 years and older. It is typically prescribed alongside other anti-seizure medications to help reduce the frequency of convulsions in people with epilepsy.

Nerve Pain After Shingles

This medication is used to treat postherpetic neuralgia (PHN) in adults. PHN is a condition characterized by persistent nerve pain that follows an outbreak of shingles. This pain occurs because the shingles virus can damage nerve fibers, leading to symptoms such as:

• Burning sensations
• Stabbing or shooting pain
• Aching that lasts long after the shingles rash has cleared

Neurontin works to manage these symptoms but does not cure the underlying conditions. It must be taken regularly as directed by a healthcare provider to remain effective.

Mechanism of Action

The exact way that Neurontin works in the human body is not fully understood. However, it is classified as an anticonvulsant or antiepileptic drug. It is thought to work by changing the way that nerves send messages to the brain and spinal cord.

Although the structure of Neurontin is similar to a brain chemical called gamma-aminobutyric acid (GABA), it does not interact with the same receptors in the brain as GABA does. Instead, researchers believe it binds to specific subunits of calcium channels in the central nervous system. This action may help to:

• Control Seizures: By stabilizing electrical activity in the brain, the medication helps prevent the excessive nerve firing that causes seizures.
• Relieve Nerve Pain: It helps dampen the transmission of pain signals from damaged nerves, specifically providing relief for postherpetic neuralgia, which is the burning or stabbing pain that can follow a shingles outbreak.

Common Side Effects

Many people using Neurontin experience mild side effects as their body adjusts to the medication. These may include:

• Dizziness or drowsiness
• Tiredness or weakness
• Unsteadiness or loss of coordination
• Nausea, vomiting, or diarrhea
• Dry mouth
• Blurred or double vision
• Swelling in the hands, ankles, or feet
• Tremors or shaking

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Mood or behavior changes: New or worsening depression, anxiety, panic attacks, irritability, or thoughts about self-harm or suicide.
• Severe allergic reactions: Fever, rash, swollen glands, or swelling of the face, lips, or tongue.
• Breathing difficulties: Slow, shallow, or labored breathing, especially if you have existing lung disease or take other sedating medications.
• Neurological issues: Increased seizure frequency or severe confusion.

Side Effects in Children

Children taking Neurontin may experience different side effects than adults, such as:

• Emotional instability or mood swings
• Hostility or aggressive behavior
• Difficulty concentrating or changes in school performance
• Restlessness or hyperactivity

Respiratory Depression

Serious, life-threatening, or fatal respiratory depression may occur with Neurontin. The risk is highest in patients with pre-existing respiratory impairment, such as chronic obstructive pulmonary disease (COPD), or in those using other medications that depress the central nervous system, including opioids. Monitoring for signs of slowed breathing or excessive sleepiness is essential.

Suicidal Ideation and Behavior

Antiepileptic drugs, including Neurontin, increase the risk of suicidal thoughts or behavior. Patients should be observed for the emergence or worsening of depression, suicidal thoughts, or any unusual changes in mood or behavior. These changes can occur as early as one week after starting treatment.

Central Nervous System Effects

Neurontin frequently causes dizziness, somnolence (drowsiness), and loss of coordination. These effects may impair the ability to drive or operate complex machinery safely. The risk of these symptoms may be increased when Neurontin is combined with alcohol or other sedating substances.

Withdrawal Seizures

Abruptly stopping Neurontin may precipitate status epilepticus or increase the frequency of seizures in patients with epilepsy. If the medication is discontinued, it is generally done gradually over a minimum of one week to reduce these risks.

Multi-organ Hypersensitivity

Serious and potentially life-threatening reactions, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), have occurred. These reactions can involve multiple organ systems, including the liver, kidneys, or heart. Symptoms may include fever, rash, and swollen lymph nodes.

Pediatric Behavioral Changes

In children ages 3 to 12, Neurontin use has been associated with neuropsychiatric adverse events. These include:

• Emotional lability (such as behavioral problems or mood swings)
• Hostility and aggressive behavior
• Hyperkinesia (restlessness or hyperactivity)
• Thought disorders (including difficulty concentrating or changes in school performance)

Pregnancy

There are no adequate and well-controlled studies regarding the use of Neurontin in pregnant women. Animal studies have indicated that the drug may cause developmental toxicity, including skeletal abnormalities, when used at certain doses. Because of these findings, healthcare providers generally only recommend Neurontin during pregnancy if the potential benefit justifies the potential risk to the fetus.

It is important not to start or stop taking Neurontin during pregnancy without medical guidance. For those treating epilepsy, stopping the medication suddenly can lead to breakthrough seizures, which may pose risks to both the pregnant person and the fetus.

Breastfeeding

Neurontin is known to be excreted in human breast milk. The effects of gabapentin exposure on a breastfeeding infant are not fully understood. Individuals who are breastfeeding should consult with their healthcare provider to weigh the benefits of breastfeeding against the potential risks of infant exposure to the medication.

Available Forms

Neurontin is an oral medication that is available in the following preparations:

• Capsules: These are hard-shell capsules intended to be swallowed whole.
• Tablets: These are solid oral tablets. Some versions are film-coated and may be scored to allow for breaking the tablet if necessary.
• Oral Solution: This is a liquid form of the medication taken by mouth, which may be used for patients who have difficulty swallowing solid pills.

FDA-Approved Indications

Neurontin (gabapentin) is approved by the U.S. Food and Drug Administration (FDA) for the following specific uses:

• Management of postherpetic neuralgia, which is chronic nerve pain that persists after a shingles (herpes zoster) infection in adults.
• Adjunctive therapy for the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years of age and older with epilepsy.

Safety Communications and Warnings

In 2019, the FDA issued a safety communication warning that serious breathing difficulties may occur in patients taking Neurontin who have existing respiratory risk factors. This risk is significantly higher in elderly patients, those with chronic obstructive pulmonary disease (COPD), and individuals taking other central nervous system (CNS) depressants, such as opioid pain medications.

Like all antiepileptic drugs, Neurontin is required by the FDA to carry a warning regarding an increased risk of suicidal thoughts or behavior. Patients and caregivers are advised to monitor for any changes in mood, symptoms of depression, or unusual behaviors.

Regulatory History and Classification

Neurontin was first approved by the FDA in 1993. While it is not currently classified as a controlled substance under federal law, some state-level regulatory agencies have implemented additional monitoring requirements or reclassified gabapentin as a controlled substance due to reports of misuse and diversion.

Withdrawal Symptoms

Stopping Neurontin suddenly can cause several withdrawal symptoms. These may include:

• Anxiety
• Difficulty falling asleep or staying asleep (insomnia)
• Nausea
• Pain
• Sweating

Seizure Risk

If you are taking Neurontin to treat a seizure disorder, stopping the medication abruptly can cause seizures to happen more often. It is important to keep taking the medication as prescribed, even if you feel better.

How to Stop Safely

You should not stop taking this medication without consulting your doctor. To minimize the risk of withdrawal, healthcare providers typically decrease the dose gradually over a period of at least one week.